Daniel Etra: Scaling the Right Level of Care

<p style="font-weight: 400;">What is the optimal level of intervention for a child with autism? How can we predict the outcome of the intervention? How many hours a week should we be spending on treatment? While these questions are often easily answered for predictable conditions like diabetes, they are much harder to pinpoint for behavioral health disabilities. </p> <p style="font-weight: 400;">Co-founder and CEO of <a href='https://www.rethinkfirst.com/'>RethinkFirst</a>, <a href='https://www.linkedin.com/in/etradaniel/'>Daniel Etra</a>, has identified a stark lack of data on treatment outcomes for behavioral health patients. To bridge this gap, Rethink delivers intervention at scale for developmental disabilities and neurodiverse conditions. </p> <p style="font-weight: 400;">In this episode, Daniel discusses Rethink’s journey to becoming an industry-leading behavioral health technology company. With decades of experience as a successful entrepreneur, Daniel shares his insights on building a successful company at scale in today’s climate.</p> <p style="font-weight: 400;">Do you have any thoughts? Please email us at <a href='mailto:hello@rosenmaninstitute.org'>hello@rosenmaninstitute.org</a>. We post new episodes every Monday. “<a href='https://rosenmaninstitute.org/podcast/'>The Health Technology Podcast</a>” is produced by <a href='https://www.linkedin.com/in/herminioneto/'>Herminio Neto</a>, hosted by <a href='https://www.linkedin.com/in/christine-winoto-8b412b/'>Christine Winoto</a>, and engineered by <a href='https://www.linkedin.com/in/aj-rojek/'>Andrew John Rojek</a></p>